Technology
How to Go 2x Long Anthropic (ANT): Leverage Shares by Themes Explains ANUU, the 2x Leveraged Anthropic ETF Launching Monday
Published
9 minutes agoon
By
Following Anthropic’s $83-per-share IPO pricing and Nasdaq trading debut at $111.50-per-share on November 19, 2026, Leverage Shares by Themes outlines how investors can gain long exposure to Anthropic stock (ANT), and where its planned 2X Long Anthropic ETF (ANUU) fits into the investment landscape.
GREENWICH, Conn., Nov. 21, 2026 /PRNewswire/ — Leverage Shares by Themes today published a step-by-step guide for investors looking to invest in Anthropic stock following the company’s highly anticipated initial public offering. Anthropic, PBC priced its IPO at $83.00 per share on November 18, 2026, above its initially proposed range of $70 to $78, with the offering totaling approximately $81.3 billion. The company’s Class A common stock began trading on Nasdaq under the ticker ANT on November 19, opening at $111.50 per share. With Anthropic now publicly traded, investors can purchase shares through brokerage accounts, while those seeking leveraged exposure can explore the planned Leverage Shares 2X Long Anthropic Daily ETF (ANUU).
How to Buy Anthropic Stock (ANT) Now That It Is Trading on Nasdaq
Following its IPO on November 19, 2026, investors can buy Anthropic (ANT) shares through a brokerage account that offers Nasdaq-listed stocks.
Step 1: Find Anthropic Stock (ANT) Through Your Brokerage
Search for Anthropic under the ticker ANT in your brokerage account. Investors no longer need to request an IPO allocation, as shares are now available for purchase on the open market during regular trading hours.
Step 2: Check the Current Share Price
Anthropic’s market price may differ significantly from its $83.00 IPO price and can fluctuate throughout the trading day. Review the latest ANT share price before placing an order.
Step 3: Choose How to Buy ANT Shares
Investors can place a market order to buy at the prevailing market price or use a limit order to specify the maximum price they are willing to pay. Given the potential volatility of newly listed stocks, investors should consider the risks of each order type before trading.
Can You Get 2X Long Exposure to Anthropic Stock?
Yes, once it launches: the Leverage Shares 2X Long Anthropic Daily ETF (ANUU) will seek daily investment results, before fees and expenses, corresponding to 200% (2X) of the daily performance of Anthropic common stock.
ANUU is not a way to buy into the IPO itself. The Fund does not take part in the offering and does not hold Anthropic shares. It is designed for knowledgeable investors who want to take a bullish daily view on Anthropic and who monitor their positions actively. Investors with a bearish daily view can use ANDD (2X short) or ANSS (1X short) once they launch.
ANUU, ANDD and ANSS are not yet trading. Their first trading date on Cboe is this coming Monday, November 23, 2026.
Ticker
ETF Name
Underlying
Asset
Exchange
Expense
Ratio
ANUU
Leverage Shares 2X Long Anthropic Daily ETF
Anthropic
Cboe
0.75 %
ANDD
Leverage Shares 2X Short Anthropic Daily ETF
Anthropic
Cboe
0.75 %
ANSS
Leverage Shares 1X Short Anthropic Daily ETF
Anthropic
Cboe
0.99 %
“Most of the questions we are getting this week are practical ones: what the ticker is, when the stock opens and how to buy it,” said Paul Marino, Chief Revenue Officer, Themes ETFs. “We want investors to have clear answers first, and to understand that ANUU is a daily 2X tool for active traders, not a substitute for owning Anthropic shares.”
Frequently Asked Questions
What Is Anthropic’s Stock Ticker?
Anthropic’s Class A common stock is expected to trade on the Nasdaq Global Select Market under the ticker ANT. ANUU, ANDD and ANSS are Leverage Shares ETF tickers, not Anthropic’s.
Is ANUU the Same as Buying Anthropic Stock?
No. ANUU will seek 2X the daily move of Anthropic stock, before fees and expenses. It does not give its investors Anthropic shares or shareholder voting rights, and its returns over periods longer than one day can differ significantly from 2X the stock’s return.
For more on how the three ETFs work, see the Leverage Shares research team’s guide, Anthropic Leveraged ETFs Explained: Long And Short
Fund pages: 2X Long Anthropic ETF (ANUU) | 2X Short Anthropic ETF (ANDD) | 1X Short Anthropic ETF (ANSS)
About Themes ETFs
Themes ETFs is a provider of thematic and single-stock leveraged ETFs, focused on delivering innovative, cost-efficient investment tools that allow investors to access the companies and trends shaping the future. Through its Leverage Shares platform, Themes ETFs offers daily leveraged and inverse ETF strategies designed for sophisticated investors and active traders.
For more information, visit www.themesetfs.com and www.leverageshares.com.
INVESTMENT INVOLVES SIGNIFICANT RISK. Funds do not invest directly in the underlying stock. As with any investment, there is a risk that you could lose all or a portion of your investment in the Funds.
An investor should carefully consider a Fund’s investment objective, risks, charges, and expenses before investing. A Fund’s prospectus and summary prospectus contain this and other information about Themes ETFs. To obtain a Fund’s prospectus and summary prospectus call 866-584-3637. A Fund’s prospectus and summary prospectus should be read carefully before investing.
Newly launched Funds have risks associated with a limited operating history.
Because of daily rebalancing and the compounding of each day’s return over time, the return of a Fund for periods longer than a single day will be the result of each day’s returns compounded over the period, which will very likely differ from the stated multiple or inverse multiple of the return of the underlying stock over the same period. The Funds are not suitable for all investors. The Funds are designed to be utilized only by knowledgeable investors who understand the potential consequences of seeking daily leveraged or inverse investment results, understand the risks associated with the use of leverage and inverse exposure, as applicable, and are willing to monitor their portfolios frequently. The Funds are not intended to be used by, and are not appropriate for, investors who do not intend to actively monitor and manage their portfolios.
Under the Investment Advisory Agreement between the Adviser and the Trust, on behalf of the Funds (the “Investment Advisory Agreement”), the Adviser has agreed to pay all expenses of the Funds, except for the fee paid to the Adviser pursuant to the Investment Advisory Agreement, interest charges on any borrowings, taxes, brokerage commissions and other expenses incurred in placing orders for the purchase and sale of securities and other investment instruments, acquired fund fees and expenses, accrued deferred tax liability, extraordinary expenses, and distribution (12b-1) fees and expenses.
Past performance does not guarantee future results.
INVESTMENT RISKS: Investing in the Funds involves a high degree of risk. As with any investment, there is a risk that you could lose all or a portion of your investment in the Funds.
Investment in leveraged and inverse products may be subject to higher volatility. The Funds do not directly invest in the underlying stock. An investment in a Fund involves risk, including the possible loss of principal. The Funds are non-diversified and include risks associated with concentrating investments in a particular industry, sector, or geographic region, which can result in increased volatility. The use of derivatives such as futures contracts and swaps is subject to market risks that may cause their price to fluctuate over time.
Risks of the Funds include effects of Compounding and Market Volatility Risk, Inverse Risk, Market Risk, Counterparty Risk, Rebalancing Risk, IntraDay Investment Risk, Daily Index Correlation Risk, Other Investment Companies (including ETFs) Risk, and risks specific to the securities of the Underlying Stock and the sector in which it operates. These and other risks can be found in the prospectus.
For periods longer than a single day, the Funds may lose money even if Anthropic’s stock price remains flat or moves in a direction consistent with a Fund’s investment objective. An investor could lose the full principal value of their investment in the Leverage Shares 2x Long Anthropic Daily ETF (ANUU) if Anthropic’s stock price declines by more than 50% in a single trading day, or in the Leverage Shares 2x Short Anthropic Daily ETF (ANDD) if Anthropic’s stock price increases by more than 50% in a single trading day. The Leverage Shares 1x Short Anthropic Daily ETF (ANSS) also carries the risk of substantial or total loss if Anthropic’s stock price rises significantly.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. The market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (NBBO) as of the time the ETF calculates current NAV per share, and do not represent the returns you would receive if you traded shares at other times. NAVs are calculated using prices as of 4:00 PM Eastern Time. Indices are unmanaged and do not include the effect of fees, expenses, or sales charges. One cannot invest directly in an index.
This information is not an offer to sell or a solicitation of an offer to buy shares of any Funds to any person in any jurisdiction in which an offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction.
Themes Management Company LLC serves as an adviser to the Themes ETFs Trust. The Funds are distributed by ALPS Distributors, Inc. (1290 Broadway, Suite 1000, Denver, Colorado 80203). ALPS is not affiliated with Anthropic or any other mentioned entity. Client brokerage services are not offered by ALPS. Please see third-party sites for more information about any mentioned services.
Themes ETFs are not sponsored, endorsed, issued, sold, or promoted by Anthropic, nor does Anthropic make any representations regarding the advisability of investing in Themes ETFs. Neither ALPS Distributors, Inc., Themes Management Company LLC nor Themes ETFs are affiliated with Anthropic.
Themes Management Company LLC and Leverage Shares are affiliates that are under common control. Themes Management Company LLC and Leverage Shares have entered into a licensing agreement in which Leverage Shares licenses the trademark LEVERAGE SHARES to Themes Management Company LLC for use in financial services in the United States.
View original content:https://www.prnewswire.com/news-releases/how-to-go-2x-long-anthropic-ant-leverage-shares-by-themes-explains-anuu-the-2x-leveraged-anthropic-etf-launching-monday-302947477.html
SOURCE Themes ETFs
You may like
Technology
Managed IT Expert Lionel Fermin Explains When a Business Needs a Fractional CIO
Published
1 hour agoon
November 21, 2026By
Lionel Fermin examines when growing businesses may need technology leadership for planning, security, spending, and long-term technology decisions.
HOBBS, N.M., Nov. 21, 2026 /PRNewswire/ — When does a business need a Fractional CIO? A HelloNation article featuring insights from Managed IT Expert Lionel Fermin of GlobaTech Solutions in Hobbs, New Mexico, explains when businesses may benefit from experienced technology leadership.
The HelloNation article explains that technology decisions often become more complicated as a business grows. New employees, software, equipment, and security risks can create challenges that basic technical support may not address. At that point, business leaders may need broader guidance about how technology supports the organization.
The article describes a Fractional CIO as someone who provides technology leadership without serving as a full-time executive. While technical support typically focuses on fixing problems and keeping systems working, this role considers how technology decisions affect employees, customers, security, costs, and future business needs.
This broader perspective can become important when several technology projects compete for attention. The article notes that businesses may recognize the need for improvements without knowing which ones should come first. Fractional CIO services can help prioritize projects according to risk, cost, and business value.
Technology planning is another major part of the role. Instead of waiting for systems or equipment to fail, the article explains that companies can prepare for equipment replacements, software changes, security improvements, and growth. Identifying major expenses early can also give leaders more time to compare options and prepare budgets.
Cybersecurity can create another need for technology leadership. The article notes that a security incident can interrupt operations, create financial losses, and affect customer relationships. Executive technology guidance can help leaders understand cybersecurity risks in business terms and determine which concerns deserve the most attention.
The article also describes how Fractional CIO services can assist with customer or industry security requirements. Businesses may receive questionnaires or requests to demonstrate specific protections. Technology leadership can help identify gaps, organize responses, and provide a clearer view of existing security practices.
Growth can also signal the need for more structured technology guidance. Systems that worked for a small team may become strained as a company adds employees. The article explains that a technology strategy can help businesses prepare for greater demands on software, networks, security, and employee access.
Vendor management is another area where stronger oversight may be useful. Companies often work with separate providers for software, internet service, phones, security, and technical support. The article notes that reviewing vendor costs, contracts, performance, and responsibilities can help reduce duplication and clarify who handles important technology needs.
Major business changes can also increase the need for planning. Opening a new office, replacing software, or hiring many employees may require coordination among leadership, employees, vendors, and technical teams. Managed IT Expert Lionel Fermin’s insights featured in the article address how technology leadership can help keep these decisions connected to broader company goals.
The article notes that not every company needs a full-time technology executive. Smaller businesses may instead need experienced guidance for certain projects or a limited number of hours. Warning signs can include rising technology costs, repeated cybersecurity concerns, unsuccessful projects, or leaders spending too much time managing technology questions.
A lack of shared planning may provide another warning sign. When departments make separate technology decisions, businesses can face higher costs, security gaps, and software problems. The article explains that a shared technology strategy can provide clearer direction across the organization.
Ultimately, the article explains that the value of a Fractional CIO centers on planning and leadership rather than daily troubleshooting. Strong technology guidance can help businesses organize decisions about systems, security, spending, growth, and long-term needs.
When a Business Needs a Fractional CIO features insights from Lionel Fermin, Managed IT Expert of Hobbs, New Mexico, in HelloNation.
About HelloNation
HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.
View original content to download multimedia:https://www.prnewswire.com/news-releases/managed-it-expert-lionel-fermin-explains-when-a-business-needs-a-fractional-cio-302947167.html
SOURCE HelloNation
Technology
HEARTBOT AI Wins Chunghwa Telecom Special Award at Meet Neo Star 2026
Published
2 hours agoon
November 21, 2026By
Named to the top 30 from more than 200 startups, AnyInsight won over judges with its zero-trust approach to AI governance
TAIPEI, Nov. 22, 2026 /PRNewswire/ — HEARTBOT AI has won the Chunghwa Telecom Special Award at Meet Neo Star 2026, the startup competition held during the Meet Taipei Startup Festival. CEO Nathan Yen pitched AnyInsight, the company’s enterprise AI security and governance platform, at the Meet Neo Star Demo Show Final on November 20, showing judges how companies can expand their use of AI agents without losing control of their data.
Alongside the judges’ awards, sponsors selected startups from the top 30 for their own prizes. HEARTBOT AI received the Chunghwa Telecom Special Award from Chunghwa Telecom (CHT), which includes priority eligibility for the final selection of the CHT 5G Accelerator Batch 9, CHT hicloud credits and opportunities to connect and collaborate with CHT business units.
Meet Taipei ran November 19 to 21 at Taipei Expo Park and drew more than 550 startups from 23 countries, its largest edition to date. In October, AnyInsight also received the ASOCIO Global Business Service Award.
Companies Want AI Agents, and Proof They Are Under Control
AI is moving beyond chat toward agents that read data, call internal systems and complete multistep tasks on their own. That changes what companies ask. The question is no longer which AI tools to use, but who can use them, what data they touch and what the agents actually did.
The gaps are already showing. Employees use personal AI accounts for work, leaving no company record. Agents built by individual teams run without IT’s knowledge, sometimes long after the people who built them have left. When auditors ask for AI usage records, teams spend weeks pulling them together by hand.
Regulation is adding pressure. The transparency obligations in Article 50 of the EU AI Act began applying in August 2026, and for Taiwanese companies that operate internationally, AI governance is now part of day-to-day operations.
One Platform for Models, Agents and Automated Workflows
AnyInsight is a zero-trust enterprise AI security and governance platform. Companies can build agents and automated workflows in a single environment, drawing on over 20 leading cloud models, 350-plus ready-to-use AI agents and more than 500 application connectors.
Every AI interaction passes through a zero-trust generative AI firewall, which uses context-aware semantic analysis to detect personal, financial and health data as well as cloud credentials, and can alert on, block or mask that content in real time. Before an agent calls a tool through the Model Context Protocol (MCP), AnyInsight checks policy and authorizes access by role under the principle of least privilege. High-risk actions require human approval, and every event is logged as exportable audit evidence.
AnyInsight Edge Takes Governance On-Premises
On November 12, HEARTBOT AI announced AnyInsight Edge, which extends the same governance to on-premises environments and AI servers. Many companies bound by data residency rules or regulation have already deployed private large language models, only to find them stuck as internal chatbots with no access to core systems such as ERP, MES and CRM.
Edge ships as a container, needs no GPU and can run in a company’s data center or integrate with an AI server’s operating system. A single control plane manages policy centrally and enforces it consistently across cloud and on-premises environments. On-premises models such as Gemma and Mistral get access to AnyInsight’s agents, automated workflows and connectors, while AI conversations, transferred data and audit logs can stay in-house.
“Companies stopped asking whether to use AI a while ago,” said Nathan Yen, CEO of HEARTBOT AI. “What holds them back is that once agents multiply, nobody can say for sure what data they touched or what they did. AnyInsight gives every AI interaction and every agent action an owner and a record. Once companies can see that, they’re willing to put AI into their core operations.”
“Recognition from the Meet Neo Star judges means a lot to a startup working on AI governance,” Yen said. “A growing number of companies now treat control as a condition for adopting AI, and that’s the problem we work on every day.”
About HEARTBOT AI
HEARTBOT AI develops trustworthy, high-assurance enterprise AI solutions. Its flagship platform, AnyInsight, is a zero-trust enterprise AI security and governance platform with a built-in generative AI firewall, role-based access control (RBAC) and auditable activity logs. AnyInsight helps organizations protect sensitive data and enforce AI governance across platforms and networks. Enterprises can securely and rapidly connect their data and business applications, adopt AI agents and automated workflows to boost productivity and knowledge management, and keep complete records ready for compliance audits.
AnyInsight is certified to ISO/IEC 27001:2022 for information security management, and its AI governance and data protection mechanisms are designed on the principles of the EU AI Act and the General Data Protection Regulation (GDPR).
More information: AnyInsight | HEARTBOT AI
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/heartbot-ai-wins-chunghwa-telecom-special-award-at-meet-neo-star-2026-302947562.html
SOURCE HEARTBOT AI Inc.
Technology
ModuleMD Continues to Strengthen Its Position in Allergy EHR Innovation with a New Generation of AI-Powered Technology
Published
2 hours agoon
November 21, 2026By
Following strong client interest in its new WISE Touch AI experience, ModuleMD showcases its expanding technology ecosystem at ACAAI 2026, bringing clinical intelligence, automated workflows and specialty-focused innovation together for allergy practices.
PHOENIX, Nov. 21, 2026 /PRNewswire/ — Allergy practices are facing a new set of expectations. Clinical documentation needs to move faster. Front-office teams are managing increasingly complex administrative workflows. Patients expect greater transparency, while practices need technology that understands the demands of specialty care.
For more than 25 years, ModuleMD has built its technology around these realities. At the 2026 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting in Phoenix, Arizona, the company brought that commitment into focus, showcasing a new generation of AI-powered capabilities designed to advance how allergy and immunology practices deliver care and manage their operations.
At Booth #1713, the conversation centered on the continued development of the ModuleMD EHR platform, particularly its latest WISE Touch AI experience. The showcase also highlighted innovations in automated skin testing, clinical documentation, conversational practice intelligence and AI-powered front-office operations.
The momentum extends beyond the conference floor. Following its recent WISE Touch first-look webinar, ModuleMD has seen considerable interest and positive feedback from existing clients, reflecting growing enthusiasm for an EHR experience designed around the way specialty practices actually work.
An EHR Built Around Allergy. Now, With AI at Its Core.
Specialty healthcare technology requires more than a general-purpose EHR with a few specialty features added to it. Allergy practices have distinct clinical, operational and revenue cycle requirements, from immunotherapy and skin testing to biologics management and recurring patient workflows.
ModuleMD’s approach has been to build around these requirements from the ground up.
Its latest development, WISE Touch AI, brings a redesigned clinical experience and multiple AI-powered capabilities into one connected platform. Rather than treating artificial intelligence as a separate application, ModuleMD is integrating it into the everyday work of clinicians and practice teams.
The result is an EHR experience built around three important areas: clinical productivity, administrative automation and access to practice intelligence.
A redesigned clinical experience brings AI-assisted documentation, clinical decision support and CPT suggestions closer to the point of care. Designed around simpler interactions and fewer manual steps, WISE Touch AI aims to reduce the administrative effort involved in documenting and managing patient encounters.
AI-powered clinical documentation with JOSH™ takes this further. JOSH converts natural conversations into structured clinical notes, helping clinicians spend less time typing and more time with patients. Supporting more than 75 languages, the technology brings conversational documentation into the clinical workflow.
ModuleMD Front Desk extends AI into practice operations through five specialized agents working across patient intake, scheduling, insurance eligibility and estimates, authorizations and referrals, coordinated by a supervisor agent. The objective is to reduce repetitive administrative work while keeping essential front-office processes connected.
ModuleMDQ™ adds another dimension through conversational practice intelligence. Instead of navigating multiple screens to locate information, practice teams can interact with their practice data using natural language and get answers that help them move work forward.
Together, these capabilities reflect a broader direction for the ModuleMD EHR: clinical workflows, administrative operations and practice intelligence working as one system.
Rethinking Skin Testing Through AI
Innovation at ModuleMD also extends into some of the most specific workflows in allergy care.
Skin testing remains a fundamental part of allergy diagnostics, but measuring and documenting wheal and flare reactions can involve repetitive manual effort. ModuleMD’s SkinSight™ technology introduces image-based AI measurement into this process.
Using images captured on a device already available to the practice, SkinSight detects and measures wheal and flare reactions, with structured results and timestamped images transferred directly into the patient’s chart.
The integration of measurement, documentation and clinical records helps reduce manual data entry while giving clinicians the ability to review and interpret results. It also supports documentation for CPT 95004.
Developed with allergy-specific workflows in mind, SkinSight reflects an important distinction in ModuleMD’s approach to AI: technology should address actual clinical tasks, not simply introduce another layer of software.
Client Interest Signals a New Chapter for the ModuleMD EHR
Product innovation is only meaningful when it makes a difference to the people using it.
ModuleMD’s recent WISE Touch first-look webinar gave existing clients an opportunity to explore the new clinical experience and its connected AI capabilities. The response reflected strong interest in the direction of the platform, particularly the opportunity to bring clinical documentation, front-office automation and practice intelligence closer together.
For ModuleMD, this engagement is part of an ongoing relationship with the specialty practices that use its technology every day.
The company continues to develop its EHR around client needs, evolving clinical workflows and the operational realities of independent specialty practices. That means looking beyond individual features to how different parts of a practice work together.
The objective isn’t simply to add more functionality. It is to make the technology more useful at every point where clinicians and their teams interact with it.
More Than an EHR: A Connected Platform for Allergy Practices
ModuleMD’s platform brings together Electronic Health Records, Practice Management, Patient Engagement, Revenue Cycle Management, Allergy Immunotherapy, Biologics and Infusion Management.
This connected foundation is particularly important for allergy practices, where clinical care and practice operations are closely linked. From patient encounters and skin testing to immunotherapy workflows, biologics administration and revenue cycle management, the technology needs to support the full operational picture.
With more than 25 years of specialty healthcare experience, continued investment in AI and a platform shaped by the needs of its clients, ModuleMD is building on its position in allergy-focused healthcare technology.
Its presence at ACAAI 2026 offered a closer look at that direction: an EHR that continues to develop, AI that works within real practice workflows, and technology designed with the specific demands of allergy care at its center.
As specialty healthcare moves toward more connected and intelligent systems, ModuleMD’s focus remains on making technology work better for the practices that depend on it.
ModuleMD. One Practice. One Platform
To know more about ModuleMD visit www.modulemd.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/modulemd-continues-to-strengthen-its-position-in-allergy-ehr-innovation-with-a-new-generation-of-ai-powered-technology-302945885.html
SOURCE ModuleMD LLC
How to Go 2x Long Anthropic (ANT): Leverage Shares by Themes Explains ANUU, the 2x Leveraged Anthropic ETF Launching Monday
Managed IT Expert Lionel Fermin Explains When a Business Needs a Fractional CIO
HEARTBOT AI Wins Chunghwa Telecom Special Award at Meet Neo Star 2026
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Coin Market5 days agoEx-Robinhood engineer pleads guilty to $125K Hyperliquid trading scheme
-
Coin Market5 days agoTrezor customer data exposed in 3rd partner breach this year
-
Near Videos5 days agoIllia Polosukhin on AI that works for you
-
Coin Market4 days agoLighter incident exposes risks beyond withdrawal controls
-
Coin Market4 days agoFed’s Waller cites Binance hack in warning over tokenized finance
-
Coin Market4 days agoGoldman Sachs reports $1.22B in Ether ETFs as ETHA share count jumps
-
Coin Market4 days agoEastern Europe crypto flows fall 7.9% as Ukraine draws $12B in stablecoins
-
Near Videos4 days agoIllia Polosukhin on giving AI users ownership
